Publication
Cannabis’ legalization and what it means for regulatory regimes worldwide
Cannabis has been considered an illegal substance globally since the creation of the Single Convention on Narcotic Drugs (The Convention) in 1961.
Cannabis
Global | Publication | October 2020
Our global Food and Agribusiness team has a deep understanding of the existing and emerging issues surrounding the global cannabis industry. Cannabis is a sector in a state of rapid transition globally, as numerous countries and states have legalized its use for either recreational or medicinal purposes in recent years. This creates a myriad of opportunities and challenges for companies considering investment in the sector, particularly in relation to investments across multiple jurisdictions. Find out what’s new in this developing industry sector.
Thought leadership
Publication
Cashing out: What private producers and retailers should know and do when they receive an offer or find a buyer
The maturation of the cannabis sector is presenting an array of opportunities to private producers and retailers.
Publication
Canadian cannabis companies come under fire
In the 12 months leading to legalization in October 2018, Canadian public companies already in the medical cannabis space experienced “jaw-dropping growth” in their market capitalizations, notwithstanding that many reported negative earnings.
Publication
Agri-tech developments in the cannabis sector
The cannabis sector is a growing and exciting sector.
Senior Advisor
Email
keira.brennan@nortonrosefulbright.com
Head of Amsterdam
Email
saskia.blokland@nortonrosefulbright.com
Partner, Norton Rose Fulbright US Consultores em Direito Estrangeiro
Email
charles.johnson@nortonrosefulbright.com
Director: Global Head of Consumer Markets
Email
rosalind.lake@nortonrosefulbright.com
Partner
Email
joseph.williams@nortonrosefulbright.com
Recent publications
Publication
HHS proposes Security Rule amendments – including new deadlines
The United States Department of Health and Human Services (HHS), through its Office for Civil Rights (OCR), issued a proposed rule to improve data protection measures in the healthcare sector.
Publication
2025 Annual Litigation Trends Survey confirms an unpredictable regulatory landscape after Loper Bright
Regulated businesses have experienced marked uncertainty since the United States Supreme Court upended the Chevron doctrine in Loper Bright Enterprises v. Raimondo on June 28, 2024.
Publication
Tariff turmoil: US tariffs and Canadian retaliatory tariffs
On February 1, US President Donald Trump signed three executive orders which impose tariffs on Canada, China, and Mexico based on declared national emergencies associated with purported illegal immigration and fentanyl imports from each country.
Subscribe and stay up to date with the latest legal news, information and events . . .